1. Agosta, J., Melda, K., and Ashbaugh, J. (November, 1994).Hawaii at the Crossroads: Opportunities to Improve Developmental Disabilities Services, The Human Services Research Institute, Salem, OR.
2. Aman, M. G., Field, C. J., and Bridgman, G. D. (1985). City-side survey of drug patterns among non-institutionalized retarded person.Appl. Res. Ment. Retard 5: 159–171.
3. Aman, M. G., Sarphare, G., Burrow, W. H. (1995). Psychotropics drugs in group homes: Prevalence and relation to demographic/psychiatric variables.Am. J. Ment. Retard 99: 500–509.
4. Aman, M. G., and Singh, N. N. (1988).Psychopharmacology of the Developmental Disabilities, Springer-Verlag, New York.
5. American Psychiatric Association Committee on Research on Psychiatric Treatments (1992). Psychopharmacological screening criteria.J. Clin. Psychiatry, 52: 184–196.